Cargando…

Validation study of the Parkinson’s Fatigue Scale in advanced Parkinson’s disease

Purpose: To validate the Parkinson’s Fatigue Scale (PFS-16) in advanced Parkinson Disease (APD) patients using the scale’s Spanish version. Patients and methods: In a clinical study for Levodopa-Carbidopa Intestinal Gel (LCIG), 59 patients were assessed over six months using the PFS-16 and other ins...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martinez-Martin, Pablo, Wetmore, John B, Arbelo, José Matías, Catalán, María José, Valldeoriola, Francesc, Rodriguez-Blazquez, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497829/ https://www.ncbi.nlm.nih.gov/pubmed/31114412 http://dx.doi.org/10.2147/PROM.S196042

Ejemplares similares

Psychometric Properties of the Apathy Scale in Advanced Parkinson's Disease
por: Wetmore, John B., et al.
Publicado: (2019)

Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson’s disease
por: Valldeoriola, Francesc, et al.
Publicado: (2021)

A Spanish Consensus on the Use of Safinamide for Parkinson’s Disease in Clinical Practice
por: Pagonabarraga, Javier, et al.
Publicado: (2020)

Erratum: Pagonabarraga, J.; et al. A Spanish Consensus on the Use of Safinamide for Parkinson’s Disease in Clinical Practice. Brain Sci. 2020, 10, 176
por: Pagonabarraga, Javier, et al.
Publicado: (2020)

Validation of the Parkinson Fatigue Scale in Chinese Parkinson's disease patients
por: Fu, Rao, et al.
Publicado: (2017)

Validation of a Spanish Version of the Lille Apathy Rating Scale for Parkinson's Disease
por: García-Ramos, Rocio, et al.
Publicado: (2014)

Prevalence of Advanced Parkinson’s Disease in Patients Treated in the Hospitals of the Spanish National Healthcare System: The PARADISE Study
por: Martínez-Castrillo, Juan Carlos, et al.
Publicado: (2021)

Applications of the European Parkinson’s Disease Association sponsored Parkinson’s Disease Composite Scale (PDCS)
por: Balestrino, Roberta, et al.
Publicado: (2019)

Parkinson’s Disease Severity at 3 Years Can Be Predicted from Non-Motor Symptoms at Baseline
por: Ayala, Alba, et al.
Publicado: (2017)

Present and Future of Parkinson’s Disease in Spain: PARKINSON-2030 Delphi Project
por: Santos García, Diego, et al.
Publicado: (2021)

Emergencies and critical issues in Parkinson’s disease
por: Simonet, Cristina, et al.
Publicado: (2020)

Living with chronic illness scale: international validation of a new self-report measure in Parkinson’s disease
por: Ambrosio, Leire, et al.
Publicado: (2016)

COPPADIS-2015 (COhort of Patients with PArkinson’s DIsease in Spain, 2015), a global –clinical evaluations, serum biomarkers, genetic studies and neuroimaging– prospective, multicenter, non-interventional, long-term study on Parkinson’s disease progression
por: Santos-García, Diego, et al.
Publicado: (2016)

Clinical Characterization of Parkinson's Disease Patients With Cognitive Impairment
por: Simon-Gozalbo, Ana, et al.
Publicado: (2020)

Erratum to: COPPADIS-2015 (COhort of Patients with PArkinson’s DIsease in Spain, 2015), a global –clinical evaluations, serum biomarkers, genetic studies and neuroimaging– prospective, multicenter, non-interventional, long-term study on Parkinson’s disease progression
por: Santos-García, Diego, et al.
Publicado: (2016)

Rasch analysis of the living with chronic illness scale in Parkinson’s disease
por: Ambrosio, Leire, et al.
Publicado: (2020)

Analysis of four scales for global severity evaluation in Parkinson’s disease
por: Martínez-Martín, Pablo, et al.
Publicado: (2016)

How I do it — asleep DBS placement for Parkinson’s disease
por: Roldan, Pedro, et al.
Publicado: (2023)

Distribution and impact on quality of life of the pain modalities assessed by the King’s Parkinson’s disease pain scale
por: Martinez-Martin, Pablo, et al.
Publicado: (2017)

Patterns of cortical thinning in nondemented Parkinson's disease patients
por: Uribe, Carme, et al.
Publicado: (2016)

Fatigue evaluated using the 16-item Parkinson Fatigue Scale (PFS-16) predicts Parkinson’s disease prognosis
por: Niimi, Yoshiki, et al.
Publicado: (2019)

Reliability and Validity of the Persian Version of the Fatigue Severity Scale in Idiopathic Parkinson's Disease Patients
por: Fereshtehnejad, Seyed-Mohammad, et al.
Publicado: (2013)

Differential Progression of Regional Hippocampal Atrophy in Aging and Parkinson’s Disease
por: Uribe, Carme, et al.
Publicado: (2018)

Discriminating cognitive status in Parkinson’s disease through functional connectomics and machine learning
por: Abós, Alexandra, et al.
Publicado: (2017)

The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson’s disease
por: Eggington, Simon, et al.
Publicado: (2013)

Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
por: Titova, Nataliya, et al.
Publicado: (2017)

The dimensionality of fatigue in Parkinson’s disease
por: Chong, Raymond, et al.
Publicado: (2018)

A tool to improve pre-selection for deep brain stimulation in patients with Parkinson’s disease
por: Wächter, Tobias, et al.
Publicado: (2010)

Structural Brain Correlations of Visuospatial and Visuoperceptual Tests in Parkinson’s Disease
por: Garcia-Diaz, Anna Isabel, et al.
Publicado: (2017)

The Possible Clinical Predictors of Fatigue in Parkinson's Disease: A Study of 135 Patients as Part of International Nonmotor Scale Validation Project
por: Metta, Vinod, et al.
Publicado: (2011)

Validation of new diagnostic criteria for fatigue in patients with Parkinson disease
por: Siciliano, Mattia, et al.
Publicado: (2022)

Gray/White Matter Contrast in Parkinson’s Disease
por: Uribe, Carme, et al.
Publicado: (2018)

Nonmotor Symptoms in LRRK2 G2019S Associated Parkinson’s Disease
por: Gaig, Carles, et al.
Publicado: (2014)

Editorial: Measurement Tools for Clinical Assessment, Characterization and Neurorehabilitation of Parkinson's Disease
por: Rodriguez-Blazquez, Carmen, et al.
Publicado: (2021)

Sex Differences in Brain and Cognition in de novo Parkinson's Disease
por: Oltra, Javier, et al.
Publicado: (2022)

Validation of a simple screening tool for early diagnosis of advanced Parkinson’s disease in daily practice: the CDEPA questionnaire
por: Martinez-Martin, Pablo, et al.
Publicado: (2018)

Cost-Effectiveness of Device-Aided Therapies in Parkinson’s Disease: A Structured Review
por: Smilowska, Katarzyna, et al.
Publicado: (2021)

Safinamide in the treatment pathway of Parkinson’s Disease: a European Delphi Consensus
por: Stocchi, Fabrizio, et al.
Publicado: (2022)

Understanding the Lexicon of Fatigue in Parkinson’s Disease
por: Mantri, Sneha, et al.
Publicado: (2020)

Fatigue in Brazilian patients with Parkinson’s disease
por: Nassif, Daniel Venturino, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f57d9jqihgvsdka5g2q8n6q03o